Human immunology
ILT4 and its R20H variant as marker of poor prognosis in Spanish patients with colorectal cancer.
Sandra Fernández-Uría, Christian Vaquero-Yuste, Elena Álvarez-González, Cristina Sánchez Del Pueblo, María Luisa Suárez-Solís, José María Mugüerza-Huguet, Antonio Arnaiz-Villena, José Manuel Martín-Villa, Ignacio Juarez
Published: 202610.1016/j.humimm.2026.111670
Abstract
BACKGROUND: Immune checkpoint blockade is proving beneficial for cancer treatment by stimulating the anti-tumor immune response. However, the lack of success in certain cancer types encourages the research of new potential targets. ILT4 (Immunoglobul…
Preview only. Read the full abstract at the source